東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Quantifying the perceived value of p...

Wong, Peter Kim-Hung.

Linked to FindBook

Google Book

Amazon

博客來

Quantifying the perceived value of pharmacy services as measured by the contingent valuation method: Focus on community pharmacy.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Quantifying the perceived value of pharmacy services as measured by the contingent valuation method: Focus on community pharmacy./
Author:	Wong, Peter Kim-Hung.
Description:	292 p.
Notes:	Chair: Raymond Jang.
Contained By:	Dissertation Abstracts International61-12B.
Subject:	Economics, General. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=9999162
ISBN:	0493069593

Quantifying the perceived value of pharmacy services as measured by the contingent valuation method: Focus on community pharmacy.
Wong, Peter Kim-Hung.

Quantifying the perceived value of pharmacy services as measured by the contingent valuation method: Focus on community pharmacy. - 292 p.

Chair: Raymond Jang.

Thesis (Ph.D.)--University of Cincinnati, 2000.

The aim of this study is to determine the costs and benefits of pharmacist-managed warfarin therapy (PMWT) at community pharmacies using the contingent valuation (CV) method. The use of CV to measure Pharmaceutical Care outcomes is at an infancy stage. CV elicits consumers' willingness to pay (WTP) for goods and services that are not available or not priced in well functioning markets. The WTP benefit measure is consistent with welfare economic theory and its applications in health care assessment are increasing. The CV survey was sent to 2,800 patients that were selected from files in community pharmacies or a rural health plan. Five hundred and thirty patients participated (393 usable) in the CV survey. Patients were divided into warfarin clinic (<italic>ex post </italic>) and non-warfarin clinic (<italic>ex ante</italic>) groups. A self-administered survey consisting of 24 questions was mailed to the respondents' home. WTP values in the form of out-of-pocket expense and additional insurance premium were elicited for PMWT with various probabilities for success in reducing blood clots and hospitalization. A payment card method was used to obtain patients' WTP values. Overall WTP values for PMWT in the form of out-of-pocket or additional insurance were significantly greater than zero. The mean out-of-pocket WTP amounts for 28% blood clot incident reduction and 26% hospitalization reduction were

ISBN: 0493069593Subjects--Topical Terms:

1017424
Economics, General.

Quantifying the perceived value of pharmacy services as measured by the contingent valuation method: Focus on community pharmacy.
LDR:03708nam 2200289 a 45 001 929263
005 20110427
008 110427s2000 eng d
020 $a 0493069593
035 $a (UnM)AAI9999162
035 $a AAI9999162
040 $a UnM $c UnM
100 1 $a Wong, Peter Kim-Hung. $3 1252748
245 1 0 $a Quantifying the perceived value of pharmacy services as measured by the contingent valuation method: Focus on community pharmacy.
300 $a 292 p.
500 $a Chair: Raymond Jang.
500 $a Source: Dissertation Abstracts International, Volume: 61-12, Section: B, page: 6418.
502 $a Thesis (Ph.D.)--University of Cincinnati, 2000.
520 $a The aim of this study is to determine the costs and benefits of pharmacist-managed warfarin therapy (PMWT) at community pharmacies using the contingent valuation (CV) method. The use of CV to measure Pharmaceutical Care outcomes is at an infancy stage. CV elicits consumers' willingness to pay (WTP) for goods and services that are not available or not priced in well functioning markets. The WTP benefit measure is consistent with welfare economic theory and its applications in health care assessment are increasing. The CV survey was sent to 2,800 patients that were selected from files in community pharmacies or a rural health plan. Five hundred and thirty patients participated (393 usable) in the CV survey. Patients were divided into warfarin clinic (<italic>ex post </italic>) and non-warfarin clinic (<italic>ex ante</italic>) groups. A self-administered survey consisting of 24 questions was mailed to the respondents' home. WTP values in the form of out-of-pocket expense and additional insurance premium were elicited for PMWT with various probabilities for success in reducing blood clots and hospitalization. A payment card method was used to obtain patients' WTP values. Overall WTP values for PMWT in the form of out-of-pocket or additional insurance were significantly greater than zero. The mean out-of-pocket WTP amounts for 28% blood clot incident reduction and 26% hospitalization reduction were $1 7.19 ± 15.57 and $1 9.26 ± 17.56 respectively. The mean WTP insurance premiums for the same probabilities were $1 1.97 ± 13.66 and $1 2.66 ± 14.63 respectively. Regression analysis was used to identify significant predictors for the WTP values. For the out-of-pocket WTP payment scheme, annual household income, selection of health plan with PMWT and attitude towards the health plan's inclusion of PMWT were significant predictors. For the insurance WTP scheme, annual household incomes and selection of health plan with PMWT were significant predictors. Patients were able to assign values to different sizes of health gains. Range bias and inconsistency of rational choices were detected from this sampled population. There were no significant differences for both WTP out-of-pocket and WTP insurance between <italic> ex ante</italic> and <italic>ex post</italic> PMWT respondents. Finally cost benefit analyses from the societal perspective were performed to assess the net benefits of having PMWT at community pharmacies at different sizes of health gains. Net benefits varied from $−88.36 to $1 05.52 depending on whether blood test cost was included in the calculation. Results indicated that PMWT should be provided only to high-risk patients otherwise the program would not have favorable net benefits.
590 $a School code: 0045.
650 4 $a Economics, General. $3 1017424
650 4 $a Health Sciences, Health Care Management. $3 1017922
650 4 $a Health Sciences, Pharmacy. $3 1017737
690 $a 0501
690 $a 0572
690 $a 0769
710 2 0 $a University of Cincinnati. $3 960309
773 0 $t Dissertation Abstracts International $g 61-12B.
790 $a 0045
790 1 0 $a Jang, Raymond, $e advisor
791 $a Ph.D.
792 $a 2000
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=9999162